| Name | German Dobson Cvs Llc |
|---|---|
| Organization Name | German Dobson Cvs Llc |
| Location | 13731 E Bell Rd, Surprise, Arizona 85374 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (623) 975-4379 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Patients with the most acute type of thrombosis in the leg - known as an arterial thrombosis - risk developing diseases that are far worse than the blood clot itself. The risk of developing cancer during the first six months after the blood clot is three times greater than normal.
A new biomarker test developed by researchers at Georgetown Lombardi Comprehensive Cancer Center and their colleagues can help predict, with up to 90 percent certainty, which chemical compounds can cause DNA damage that could lead to cancer.
Merck, known as MSD outside the United States and Canada, and Intercell AG (VSE: ICLL) today announced that following a detailed analysis of the data from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus (S. aureus) infection, the independent Data Monitoring Committee (DMC) has unanimously recommended termination of the study.
ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, announced today that the first planned review of data related to patient enrollment in the CIRC (Circulation Improving Resuscitation Care) Trial by the trial Data Safety Monitoring Board (DSMB) has been completed and the trial is proceeding with patient enrollment as originally designed.
› Verified 3 days ago
| NPI Number | 1366464141 |
| Organization Name | GERMAN DOBSON CVS LLC |
| Doing Business As | CVS PHARMACY #16675 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 13731 W Bell Rd, Surprise, AZ 85374 |
| Phone Number | 623-975-4379 |
News Archive
Patients with the most acute type of thrombosis in the leg - known as an arterial thrombosis - risk developing diseases that are far worse than the blood clot itself. The risk of developing cancer during the first six months after the blood clot is three times greater than normal.
A new biomarker test developed by researchers at Georgetown Lombardi Comprehensive Cancer Center and their colleagues can help predict, with up to 90 percent certainty, which chemical compounds can cause DNA damage that could lead to cancer.
Merck, known as MSD outside the United States and Canada, and Intercell AG (VSE: ICLL) today announced that following a detailed analysis of the data from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus (S. aureus) infection, the independent Data Monitoring Committee (DMC) has unanimously recommended termination of the study.
ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, announced today that the first planned review of data related to patient enrollment in the CIRC (Circulation Improving Resuscitation Care) Trial by the trial Data Safety Monitoring Board (DSMB) has been completed and the trial is proceeding with patient enrollment as originally designed.
› Verified 3 days ago
News Archive
Patients with the most acute type of thrombosis in the leg - known as an arterial thrombosis - risk developing diseases that are far worse than the blood clot itself. The risk of developing cancer during the first six months after the blood clot is three times greater than normal.
A new biomarker test developed by researchers at Georgetown Lombardi Comprehensive Cancer Center and their colleagues can help predict, with up to 90 percent certainty, which chemical compounds can cause DNA damage that could lead to cancer.
Merck, known as MSD outside the United States and Canada, and Intercell AG (VSE: ICLL) today announced that following a detailed analysis of the data from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus (S. aureus) infection, the independent Data Monitoring Committee (DMC) has unanimously recommended termination of the study.
ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, announced today that the first planned review of data related to patient enrollment in the CIRC (Circulation Improving Resuscitation Care) Trial by the trial Data Safety Monitoring Board (DSMB) has been completed and the trial is proceeding with patient enrollment as originally designed.
› Verified 3 days ago
Cvs Pharmacy # 01743 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 13870 W Greenway Rd, Surprise, Arizona 85374 Phone: (623) 546-0512 | |
Cvs Pharmacy #05477 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 15474 W Greenway Rd, Surprise, Arizona 85374 Phone: (623) 584-1964 | |
Cvs Pharmacy #05530 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 15300 N Cotton Lane, Surprise, Arizona 85388 Phone: (623) 584-8558 | |
Cvs Pharmacy #09306 Type: Pharmacy Location: 19505 N Sunrise Blvd, Surprise, Arizona 85374 Phone: (623) 556-4778 | |
German Dobson Cvs Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 13731 E Bell Rd, Surprise, Arizona 85374 Phone: (623) 975-4379 |